Does the duration of empiric antibiotic treatment influence NEC incidence and severity relative to placental pathology?
Journal of Neonatal-Perinatal Medicine · 2025
DOI: 10.1177/19345798251387332 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neonatal-Perinatal Medicine, 2025. Verfasst von Parvesh Mohan Garg und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics/Neonatology, Atrium Health Wake Forest Baptist, Wake Forest School of Medicine, Winston Salem, NC, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Enterocolitis, Necrotizing, Placenta, Chorioamnionitis. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
Necrotizing enterocolitis (NEC) remains a leading cause of mortality in preterm infants. Studies show that exposure to chorioamnionitis is associated with increased rate of NEC. The influence of the early antibiotic exposure provides contrasting findings, with a few studies demonstrating an increased risk of NEC with prenatal and postnatal antibiotic treatment, and others showing a decreased NEC risk. Far fewer reports delineate the impact of the duration of early antibiotics or the potential confounding of antibiotics by placental pathology on incidence of NEC. The provision of antibiotics following birth is associated with increased risk of NEC secondary to changes in the gut microbiome, intestinal epithelium maturation, and the intestinal barrier function. This report presents current evidence about the clinical impact of intrauterine environment and postnatal antibiotic exposure on the intestinal injury in preterm infants. We present information from our own research in conjunction with information collected from an extensive search in the databases PubMed, EMBASE, and Scopus. Both translational and prospective clinical studies are needed to fully understand the combined impact of placental pathology and postnatal antibiotic exposure on the neonatal morbidities and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics/Neonatology, Atrium Health Wake Forest Baptist, Wake Forest School of Medicine, Winston Salem, NC, USA.
- Division of Neonatology, Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
- Department of Immunobiology, Human and Translational Immunology Program, Department of Obstetrics Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
- Department of Pediatrics/Neonatology, UCLA Mattel Children's Hospital, Los Angeles, CA, USA.
- Department of Pediatrics/Neonatology, Connecticut Children's, Hartford, CT, USA.
ORCID-Profile: Parvesh Mohan Garg
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Garg, P. M., Konnikova, L., Kallapur, S. G., & Shenberger, J. S. (2025). Does the duration of empiric antibiotic treatment influence NEC incidence and severity relative to placental pathology?. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.1177/19345798251387332
Vancouver
Garg PM, Konnikova L, Kallapur SG, Shenberger JS. Does the duration of empiric antibiotic treatment influence NEC incidence and severity relative to placental pathology?. Journal of Neonatal-Perinatal Medicine. 2025. doi:10.1177/19345798251387332
BibTeX
@article{Garg2025,
author = {Garg, Parvesh Mohan and Konnikova, Liza and Kallapur, Suhas G and Shenberger, Jeffrey S},
title = {Does the duration of empiric antibiotic treatment influence NEC incidence and severity relative to placental pathology?},
journal = {Journal of Neonatal-Perinatal Medicine},
year = {2025},
doi = {10.1177/19345798251387332}
}
EUVIMED